Top Markets
Coin of the day
Microba Life Sciences Limited Microba Life Sciences Limited

Microba Life Sciences Limited

MAP
Rank in Stocks #28063
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Share Price
$0.04020123
Market Cap
$28.83M
Change (1 day)
0.00%
Change (1 year)
-31.34%
Country
AU
Trade Microba Life Sciences Limited (MAP)

Category

Stock price history for Microba Life Sciences Limited (MAP)
Highest end of day price: $0.04 on 2026-08-01

Lowest end of day price: $0.27 on 2022-04-01
Stock price history of Microba Life Sciences Limited from 2022 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -0.56%
2025 -58.06%
2024 -14.98%
2023 -33.14%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$614.87 24.26%
US
$211.90 0.24%
US
$24.33 90.18%
CN
$323.81 101.57%
US
$566.78 -11.42%
US